Takaisin Tulosta

Triglyseridit ateroskleroosin etiologiassa

Lisätietoa aiheesta
Niina Matikainen ja Timo Strandberg


  1. Krauss RM. Atherogenicity of triglyceride-rich lipoproteins. Am J Cardiol 1998;81:13B-17B «PMID: 9526808»PubMed
  2. Sarwar N, Danesh J, Eiriksdottir G ym. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007;115:450-8 «PMID: 17190864»PubMed
  3. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9 «PMID: 8836866»PubMed
  4. Bansal S, Buring JE, Rifai N ym. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 2007;298:309-16 «PMID: 17635891»PubMed
  5. Nordestgaard BG, Benn M, Schnohr P ym. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 2007;298:299-308 «PMID: 17635890»PubMed
  6. Jørgensen AB, Frikke-Schmidt R, West AS ym. Genetically elevated non-fasting triglycerides and calculated remnant cholesterol as causal risk factors for myocardial infarction. Eur Heart J 2013;34:1826-33 «PMID: 23248205»PubMed
  7. Do R, Willer CJ, Schmidt EM ym. Common variants associated with plasma triglycerides and risk for coronary artery disease. Nat Genet 2013;45:1345-52 «PMID: 24097064»PubMed
  8. Tabas I, Williams KJ, Borén J. Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications. Circulation 2007;116:1832-44 «PMID: 17938300»PubMed
  9. Catapano AL, Graham I, De Backer G ym. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J 2016;37:2999-3058 «PMID: 27567407»PubMed
  10. Emerging Risk Factors Collaboration., Di Angelantonio E, Gao P ym. Lipid-related markers and cardiovascular disease prediction. JAMA 2012;307:2499-506 «PMID: 22797450»PubMed
  11. Boekholdt SM, Arsenault BJ, Mora S ym. Association of LDL cholesterol, non-HDL cholesterol, and apolipoprotein B levels with risk of cardiovascular events among patients treated with statins: a meta-analysis. JAMA 2012;307:1302-9 «PMID: 22453571»PubMed
  12. Robinson JG, Wang S, Jacobson TA. Meta-analysis of comparison of effectiveness of lowering apolipoprotein B versus low-density lipoprotein cholesterol and nonhigh-density lipoprotein cholesterol for cardiovascular risk reduction in randomized trials. Am J Cardiol 2012;110:1468-76 «PMID: 22906895»PubMed
  13. Lawler PR, Kotrri G, Koh M ym. Real-world risk of cardiovascular outcomes associated with hypertriglyceridaemia among individuals with atherosclerotic cardiovascular disease and potential eligibility for emerging therapies. Eur Heart J 2020;41:86-94 «PMID: 31733058»PubMed